
"These findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19," say public health researchers led by Yair Lewis, of Ben-Gurion University of the Negev in Beer-Sheva, Israel.
They report their findings Feb. 26 in Morbidity and Mortality Weekly Report, a journal of the U.S. Centers for Disease Control and Prevention.
With its 9 million people and highly organized, well-supplied COVID-19 vaccine rollout program, many see Israel as a harbinger of what's to come for other, larger countries once vaccines have been delivered into the arms of most citizens.
Like other nations, Israel has been hit hard by SARS-CoV-2: More than 700,000 cases and 5,200 deaths had been reported as of Feb. 9, Lewis' team said.
But beginning Dec. 20, Israel began a massive vaccination campaign, prioritizing older Israelis.
By early February, two doses of the highly effective Pfizer vaccine had been delivered to 84% of all Israelis age 70 and older, the research team said.
How is that success impacting the health of older Israelis?
To find out, Lewis' group compared rates of severe, life-threatening COVID-19 (requiring use of a ventilator) in people over the age of 69 with that of patients aged at or under 50 years. By Feb. 9, only about 10% of these younger Israelis had gotten both doses of the Pfizer vaccine.
They report that in the fall -- prior to the vaccine rollout -- for every one COVID-19 patient under 50 with severe COVID-19, there were about six more aged 70 or older who were hooked up to the lifesaving machines.
But by Feb. 9, that ratio had dropped dramatically, so that for every 1 young patient with severe COVID-19, there were about 2 aged 70 or over. That's a 67% drop overall.
And the hope is that as vaccines reach the bulk of younger Israelis, numbers of severe COVID-19 cases will continue to fall among all age groups.
Lewis' group stressed that it took more than just vaccines to keep SARS-CoV-2 transmission down.
"Non-pharmaceutical interventions have included three national stay-at-home orders, multiple rounds of school closures, restrictions on commercial activity and travel, and a mask mandate, among others," Lewis' group noted.
But the Pfizer vaccine's high effectiveness has also been key. Indeed, on Feb. 19, Pfizer said its latest data — from 9,000 employees at Israel's largest hospital — suggests that just one dose of its vaccine may provide 85% protection against SARS-CoV-2.
More information:
There's more on COVID-19 vaccination at the CDC.
SOURCE: Morbidity and Mortality Weekly Report, Feb. 26, 2021
There May Be 6 Types of COVID-19
'What's Wrong With Me?' Young COVID Survivors Battle Long-Haul Symptoms
Stuck at Home, Suffering With COVID? Experts Offer Guidance on Care
COVID-19 Typically Mild for Babies: Study
Preventing COVID Means Wearing Masks While Social Distancing: Study
Prior Exposure to Common Cold Won't Shield You From COVID: Study
Prior Exposure to SARS Virus Provides Little Protection Against New Coronavirus
Could COVID-19 Someday Become Seasonal, Like Flu?
Brush With Common Cold Might Help Protect Against COVID-19
Immune System May 'Remember' Infections From Previous Coronaviruses
Ample Vitamins May Shield You From Colds
Vaccines Saved 37 Million Lives, Mostly Children, Over Past Two Decades
COVID Survivor Rita Wilson Wants You to Get Your Flu Shot
Not the Flu: COVID Death Risk Is 3.5 Times That of Influenza
With 'Twindemic' Looming, 2 out of 5 Americans Plan to Skip Flu Shot